Loading your workspacePreparing the page and its market data.
Polymarket wallet 0xa4744e97e961cfdbf513911522e343ed390bfd60 · on Polymarket since Jun 12, 2026
| Market | Holding | Paid → now | |||
|---|---|---|---|---|---|
| FDA approves GSK & Spero Therapeutics' Tebipenem HBr?Settled - ready to redeem | No | 110 | 42¢ → 0¢ | $0 | −$46 −100% |
| Will S&P 500 (SPY) hit (LOW) $720 in June?Settled - ready to redeem | Yes | 83 | 24¢ → 0¢ | $0 | −$20 −100% |
| FDA approves Viridian Therapeutics' Veligrotug?Settled - ready to redeem | No | 200 | 31¢ → 0¢ | $0 | −$62 −100% |
| When | Market | Bet | Size |
|---|---|---|---|
| 121d | Will S&P 500 (SPY) hit (LOW) $720 in June? | BuyYes24¢ | $21 |
| 130d | FDA approves GSK & Spero Therapeutics' Tebipenem HBr? | SellNo33¢ | $45 |
| 130d | FDA approves GSK & Spero Therapeutics' Tebipenem HBr? | BuyNo57¢ | $4 |
| 130d | FDA approves GSK & Spero Therapeutics' Tebipenem HBr? | BuyNo57¢ | $31 |
| 130d | FDA approves GSK & Spero Therapeutics' Tebipenem HBr? | BuyNo44¢ | $4 |
| 130d | FDA approves GSK & Spero Therapeutics' Tebipenem HBr? | BuyNo40¢ | $12 |
| 130d | FDA approves GSK & Spero Therapeutics' Tebipenem HBr? | BuyNo36¢ | $56 |
| 130d | FDA approves Viridian Therapeutics' Veligrotug? | BuyNo33¢ | $16 |
| 131d | FDA approves Viridian Therapeutics' Veligrotug? | BuyNo31¢ | $32 |
| 131d | FDA approves Viridian Therapeutics' Veligrotug? | BuyNo30¢ | $2 |
| 133d | FDA approves Viridian Therapeutics' Veligrotug? | BuyNo30¢ | $6 |
| 133d | FDA approves Viridian Therapeutics' Veligrotug? | BuyNo30¢ | $5 |
| 133d | FDA approves Viridian Therapeutics' Veligrotug? | BuyNo30¢ | $3 |
| 133d | FDA approves Viridian Therapeutics' Veligrotug? | BuyNo31¢ | $1 |
Sources: Polymarket's Data API (positions, closed positions, activity, portfolio value and the all-time leaderboard) and its public profiles, read every five minutes. Recent hit rate is the share of the wallet's last 50 closed positions that made money. All-time profit and rank are Polymarket's own.